RedHill Biopharma (RDHL) News Today → Trump’s Gift Could Unleash $51 Billion in New Wealth (From Wealthpin Pro) (Ad) Free RDHL Stock Alerts $0.46 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29, 2024 | americanbankingnews.comRedHill Biopharma (NASDAQ:RDHL) Now Covered by Analysts at StockNews.comMay 28, 2024 | americanbankingnews.comRedHill Biopharma (NASDAQ:RDHL) Share Price Crosses Below Two Hundred Day Moving Average of $0.75May 22, 2024 | uk.finance.yahoo.comPensioners win £9,000 back in 16-year council tax battleMay 7, 2024 | finanznachrichten.deRedHill Biopharma Ltd.: RedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035May 6, 2024 | prnewswire.comRedHill Announces New Opaganib Chinese Patent Against Ebola Virus Valid Through 2035April 24, 2024 | finance.yahoo.comRedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 StudyApril 10, 2024 | finance.yahoo.comRedHill Biopharma Full Year 2023 Earnings: EPS: US$4.00 (vs US$46.29 loss in FY 2022)April 9, 2024 | bizjournals.comRaleigh pharma weighs divesting commercial operationsApril 8, 2024 | finanznachrichten.deRedHill Biopharma Ltd.: RedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsApril 8, 2024 | finance.yahoo.comRedHill Biopharma Ltd. (2RH0.F)April 8, 2024 | prnewswire.comRedHill Biopharma Announces Full-Year 2023 Results and Operational HighlightsApril 2, 2024 | finance.yahoo.comRedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market PriceMarch 11, 2024 | markets.businessinsider.comRedHill Biopharma Receives New Patent For H. Pylori Treatment TaliciaMarch 11, 2024 | finance.yahoo.comRedHill Announces New USPTO Patent Covering Talicia® Through 2034March 5, 2024 | finance.yahoo.comRedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures ProgramsFebruary 20, 2024 | finance.yahoo.comRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationFebruary 20, 2024 | prnewswire.comRedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New PublicationFebruary 16, 2024 | barrons.comRedHill Biopharma Ltd. ADRJanuary 26, 2024 | finance.yahoo.comRedHill Biopharma Announces Closing of $8 Million Registered Direct OfferingJanuary 25, 2024 | msn.comRedHill gains after new patent grant for Talicia for H. pylori treatment through 2042January 25, 2024 | finance.yahoo.comRedHill Announces New USPTO Patent Grant for Talicia® for H. pylori Treatment Through 2042January 25, 2024 | finance.yahoo.comRedHill Biopharma Announces $8 Million Registered Direct OfferingJanuary 24, 2024 | benzinga.comWhy Redhill Biopharma Stock Is Moving HigherDecember 20, 2023 | msn.comRedHill's Investigational COVID-19 Drugs Combined With Gilead's Show Effect Against EbolaDecember 20, 2023 | markets.businessinsider.comRedHill Announces Results Of A New U.S. Army-funded In Vivo Ebola Virus StudyDecember 20, 2023 | msn.comRedHill shares rally 20% on positive data for two antiviral drugsDecember 20, 2023 | finance.yahoo.comRedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against EbolaDecember 12, 2023 | msn.comRedHill Biopharma regains compliance with Nasdaq listing ruleDecember 4, 2023 | finance.yahoo.comRedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 StudyNovember 30, 2023 | benzinga.comRedhill Biopharma Stock (NASDAQ:RDHL), Short Interest ReportNovember 29, 2023 | msn.comWhat's Going On With Redhill Biopharma Stock?November 29, 2023 | marketbeat.comTrading was temporarily halted for "RDHL" at 10:11 AM with a stated reason of "LULD pause."November 28, 2023 | marketbeat.comTrading was temporarily halted for "RDHL" at 10:11 AM with a stated reason of "LULD pause."November 28, 2023 | marketbeat.comTrading was temporarily halted for "RDHL" at 09:11 AM with a stated reason of "LULD pause."November 27, 2023 | investorplace.com5 Investors Betting Big on RedHill Biopharma (RDHL) StockNovember 27, 2023 | msn.comWhy Is Gastrointestinal Disease Focused-RedHill Biopharma Stock Higher Over 100% Today?November 27, 2023 | markets.businessinsider.comRedHill's Talicia Granted 5-year Market Exclusivity By FDANovember 27, 2023 | finance.yahoo.comRedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia® with IP Protection Running to 2034November 22, 2023 | finance.yahoo.comRedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital MarketOctober 19, 2023 | benzinga.comThe Street Reports: Guide to Penny Stocks Look Now! CLNV, ARAV, RDHL, ATHX, EPAZOctober 3, 2023 | msn.comIsrael-Based Penny Stock RedHill Biopharma Is Trading Higher Today - Here's Why?October 3, 2023 | finance.yahoo.comRedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo StudySeptember 5, 2023 | finance.yahoo.comRedHill Announces New USPTO Notice of Patent Allowance for Opaganib and EU Patent Grant for RHB-102 (BEKINDA®)August 17, 2023 | finance.yahoo.comRedHill Biopharma Provides H1/23 Financial Results and Operational HighlightsJuly 31, 2023 | finance.yahoo.comRedHill's RHB-107 Included in U.S. Government-Supported COVID-19 Platform Trial and Cleared for Initiation by FDAJuly 25, 2023 | finance.yahoo.comRedHill Biopharma Announces Closing of $3.8 Million Registered Direct Offering and Warrant ExerciseJuly 21, 2023 | benzinga.comWhat's Going On With RedHill Biopharma Stock TodayJuly 21, 2023 | finance.yahoo.comRedHill Biopharma Announces Registered Direct Offering and Warrant Exercise for $3.8 Million Gross ProceedsJuly 21, 2023 | marketbeat.comTrading was temporarily halted for "RDHL" at 09:07 AM with a stated reason of "LULD pause."July 21, 2023 | finance.yahoo.comRedHill Announces Additional U.S. Government Funding for Opaganib Nuclear Countermeasure Development Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. RDHL Media Mentions By Week RDHL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RDHL News Sentiment▼0.850.76▲Average Medical News Sentiment RDHL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RDHL Articles This Week▼31▲RDHL Articles Average Week Get RedHill Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for RDHL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: AEON Biopharma News Today Anebulo Pharmaceuticals News Today Tharimmune News Today Kezar Life Sciences News Today Equillium News Today Eagle Pharmaceuticals News Today CASI Pharmaceuticals News Today Aadi Bioscience News Today Kronos Bio News Today Lexaria Bioscience News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RDHL) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding RedHill Biopharma Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
